MARC보기
LDR01526camuu2200289 a 4500
001000000707922
00520080828164116
008070918s2008 mdu b 001 0 eng d
010 ▼a 2007038609
020 ▼a 9781847205995(hardcover): ▼c GBP69.95
040 ▼a DLC ▼c DLC ▼d 225009
05000 ▼a K1575 ▼b .H37 2008
08200 ▼a 346.04/86 ▼2 22
090 ▼a 346.0486 ▼b 008a
0930 ▼a 1095263 ▼x 법학
1001 ▼a Haracoglou, Irina, ▼d 1981-.
24510 ▼a Competition law and patents: ▼b a follow-on innovation perspective in the biopharmaceutical industry/ ▼c by Irina Haracoglou.
260 ▼a Northampton, MA,: ▼b Edward Elgar, ▼c 2008.
300 ▼a xx, 251 p; ▼c cm.
4900 ▼a New horizons in competition law and economics series
504 ▼a Includes bibliographical references (p. 200-238) and index.
5050 ▼a Biopharmaceutical R&D : the increased importance of cumulative innovation and related concerns -- The patent system as a system of balancing -- The patent system and some potential safety nets -- The right to health as an interpretive principle of patent law -- Unilateral conduct, IPRs and competition law : a systems' interaction -- The duty to deal under Art. 82 EC -- The duty to deal as applied to address technology access problems in the biopharmaceutical industry.
6500 ▼a Patent laws and legislation.
6500 ▼a Pharmaceutical biotechnology ▼x Patents.
6500 ▼a Pharmaceutical biotechnology ▼x Law and legislation.
6500 ▼a Competition, Unfair.
990 ▼a 신정선 ▼b 신정선